Brief: Alkem Labs Says Alkem Medtech To Buy 51%-55% Of Occlutech
13/02/2026 09:36
Feb 13 (Reuters) - Alkem Laboratories Ltd ALKE.NS: ALKEM MEDTECH TO BUY 51%-55% OF OCCLUTECH TOTAL EQUITY VALUE IS EUR 180.70 MILLION Source text: ID:nBSE4gygN5 Further company coverage: ALKE.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees